Last reviewed · How we verify
NCT05056766: OAMMM
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
trial testing questionnaires: Epworth Sleepiness Scale; Pichot fatigue questionnaire. in Sleep Apnea Syndromes in 20 participants. Completed in 1 September 2022.
1 September 2022
Quick facts
| Lead sponsor | Centre Hospitalier de Valence |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 September 2021 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- questionnaires: Epworth Sleepiness Scale; Pichot fatigue questionnaire.
Conditions studied
- Sleep Apnea Syndromes — all drugs for Sleep Apnea Syndromes →
- Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →
- Respiratory Tract Diseases — all drugs for Respiratory Tract Diseases →
Sponsor
Centre Hospitalier de Valence
Who can join
18 and older, any sex, with Sleep Apnea Syndromes or Sleep Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The OAMMM study is a mono-centrer , non interventional, prospective study, carried out in CH Valence Oral Appliance is indicated for first line moderate sleep Apnea Syndrome or severe sleep Apnea Syndrome after failure of positive airway pressure (CPAP). Clinical impact of each mm advancement of Oral Appliance is imperfectly assessed. The study aim to assess clinical and paraclinical efficacy of an oral Appliance on each mm of advancement.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05056766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Apnea Syndromes
Currently open trials in the same condition.
- NCT06578390 — Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis · NA · recruiting
- NCT07086599 — Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Pari · recruiting
- NCT04399200 — Apnea, Stroke and Incident Cardiovascular Events · recruiting
- NCT04234828 — Validation of Withings Sleep for the Detection of Sleep Apnea Syndrome · active not recruiting
Other Centre Hospitalier de Valence trials
Trials by the same sponsor.
- NCT06184880 — Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer · NA · recruiting
- NCT05618392 — Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors · recruiting
- NCT05227157 — GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers · completed
- NCT05150470 — Evaluation of the Dental Movements Caused by Oral Appliance in Sleep Apnea Syndrome · NA · completed
- NCT05497947 — Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLarynge · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05056766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Valence
- Last refreshed: 8 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05056766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing